跳至主要内容
临床试验/NCT00590525
NCT00590525已完成不适用

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

Creighton University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2004年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
We hypothesize that a higher hsCRP is associated with higher failure rates in patients undergoing cardioversion for atrial fibrillation

研究概览

简要总结

The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

We hypothesize that a higher hsCRP is associated with higher failure rates in patients undergoing cardioversion for atrial fibrillation

时间窗: 1 month

次要结局

  • secondary endpoint will be if a new inflammatory disease state is diagnosed at the one-month mark.(1 month)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Inflammation as a Predictor in Cardioversion of... | 临床试验